At Revive Low T Clinic, we work with Aetna members navigating GLP-1 coverage regularly
Naunyn-Schmiedeberg's Arch Pharmacol 396 , 13611370 (2023)
Notably, among patients with T2DM and liver biopsy data (n = 12 studies involving 2,733 patients), the global pooled prevalence of MASH, significant fibrosis, and advanced fibrosis was 66.4 %, 40.8 %, and 15.5 %, respectively (Younossi et al., 2024[87])
The reason I looked to begin with is the first RX I had received gave me maybe 3 - .25ML shots
Om du vill frdjupa dig kring GLP-1 kan vi tipsa om en superintressant djupintervju (p engelska) om att behandlas med Ozempic hr (oroa er inte ver titeln p podcasten, det r bara clickbait)